Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

B Plasma

Figure 11.4 Chromatograms of plasma samples on a silica-chiralcel OJ coupled column system (a) plasma spiked with oxprenolol (internal standard) (b) plasma spiked with 040 p-g/ml metyrapone and 0.39 p-g/ml metyrapol (racemate) (c) plasma sample obtained after oral administration of 750 mg metaiypone. Peaks are as follows 1, metyrapone 2, metyrapol enantiomers 3, oxprenolol. Reprinted from Journal of Chromatography, 665, J. A. Chiarotto and I. W. Wainer, Determination of metyrapone and the enantiomers of its chfral metabolite metyrapol in human plasma and urine using coupled achfral-chfral liquid cltro-matography, pp. 147-154, copyright 1995, with permission from Elsevier Science. Figure 11.4 Chromatograms of plasma samples on a silica-chiralcel OJ coupled column system (a) plasma spiked with oxprenolol (internal standard) (b) plasma spiked with 040 p-g/ml metyrapone and 0.39 p-g/ml metyrapol (racemate) (c) plasma sample obtained after oral administration of 750 mg metaiypone. Peaks are as follows 1, metyrapone 2, metyrapol enantiomers 3, oxprenolol. Reprinted from Journal of Chromatography, 665, J. A. Chiarotto and I. W. Wainer, Determination of metyrapone and the enantiomers of its chfral metabolite metyrapol in human plasma and urine using coupled achfral-chfral liquid cltro-matography, pp. 147-154, copyright 1995, with permission from Elsevier Science.
B. Plasma Proteins Are Generally Synthesized ON Membrane-Bound Polyribosomes ... [Pg.581]

G4. Gardlund, B., Sjolin, J., Nilsson, A., Roll, M., Wickerts, C.-J., and Wretlind, B., Plasma levels of cytokines in primary septic shock in humans Correlation with disease severity. J. Infect. Dis. 172,296-301 (1995). [Pg.116]

Gruen, D. M., Vepfek, S., and Wright, R. B. Plasma-Materials Interactions and Impurity Control in Magnetically Confined Thermonuclear Fusion Machines. 89, 45-105 (1980). [Pg.165]

FIGU RE 1.38 Chromatograms of LPME-treated drug-free plasma, mirtazapine enantiomers, and mefloquine.156 Chromatograms refer to drug-free plasma (A) plasma spiked with 62.5 ng mL-1 of (+)-(5)-mirtazapine (2) and (-)-(i )-mirtazapine (3) and 500 ng rnL-1 of (R, S)-mefloquine (1,4) (B) plasma sample from a patient treated with 15 mg/day of rac-mirtazapine (C). All samples were pre-treated by LPME. The analysis was performed on a Chiralpak AD column using hexane ethanol (98 2, v/v) plus 0.1% diethylamine at a flow rate of 1.5 mL min-1, A = 292 nm. (+)-(5)-mirtazapine (2), (-)-(f )-mirtazapine (3) and (1, 4) internal standard. (Reproduced with permission from Elsevier.)... [Pg.45]

Fig. 2.85. Examples of chromatograms, (a) extract of 1ml blank plasma (b) plasma sample obtained from a female healthy subject 2h after oral administration of a Daflon tablet (diosmin/hesperidin, 450/50 mg) containing 61.2 ng/ml of diosmetin. Peaks I = internal standard, 7-ethoxycoumarin II = diosmetin. Reprinted with permission from F. I. Kanaze el al. [205]. Fig. 2.85. Examples of chromatograms, (a) extract of 1ml blank plasma (b) plasma sample obtained from a female healthy subject 2h after oral administration of a Daflon tablet (diosmin/hesperidin, 450/50 mg) containing 61.2 ng/ml of diosmetin. Peaks I = internal standard, 7-ethoxycoumarin II = diosmetin. Reprinted with permission from F. I. Kanaze el al. [205].
Fig. 3.29. Upper lane (a) plasma blank (b) plasma standard RCA 10 jUg/ml and (c) plasma sample RCA 8.72 jUg/ml, I.S. 10 pg/ml. Lower lane (a) brain tissue blank (b) brain standard RCA 10 jUg/ml and (c) brain sample RCA 1.04 jUg/ml, I.S. 10 pg/ml. Reprinted with permission from R. Pirola et al. [108],... Fig. 3.29. Upper lane (a) plasma blank (b) plasma standard RCA 10 jUg/ml and (c) plasma sample RCA 8.72 jUg/ml, I.S. 10 pg/ml. Lower lane (a) brain tissue blank (b) brain standard RCA 10 jUg/ml and (c) brain sample RCA 1.04 jUg/ml, I.S. 10 pg/ml. Reprinted with permission from R. Pirola et al. [108],...
Fig. 5.2,. Scunning cicciron micropholographs of (a) untreated and (b) plasma treated (120 s) Tekmilon UHMWPE fibers. After Tissington et al. (1991). Reproduced by permission of Chapman Hall. Fig. 5.2,. Scunning cicciron micropholographs of (a) untreated and (b) plasma treated (120 s) Tekmilon UHMWPE fibers. After Tissington et al. (1991). Reproduced by permission of Chapman Hall.
H Bs Ag Vaccination against hepatitis B Plasma of hepatitis B carriers... [Pg.13]

Figure 4 (A) Plasma levels of hypericin in the presence ( ) and absence ( ) of pro-cyanidin B2. (B) Plasma levels of hypericin in the presence ( ) and absence (o) of hyperoside. Source From Ref. 19. Figure 4 (A) Plasma levels of hypericin in the presence ( ) and absence ( ) of pro-cyanidin B2. (B) Plasma levels of hypericin in the presence ( ) and absence (o) of hyperoside. Source From Ref. 19.
Fig. 30 images of a 50 50 SBR/EPDM blend with (a) 40 phr fullerene carbon black (b) plasma-coated fullerene carbon black (c) unstained section with fullerene carbon black (d) unstained section with plasma-coated fullerene carbon black... [Pg.211]

Fig. 7.3.6a,b Plasma porphyrins from an individual with porphyria cutanea tarda (a) and from an individual with congenital erythropoietic porphyria (b)... [Pg.770]

Hygromycin B Plasma, H3PO4 (plasma) or 20 LHK-PD Silica Acetone/EtOH/ Fluorometric/ 25-50 ppb/ 327... [Pg.1011]

Fig. 14. Comparison of the current-voltage curves of a smooth nickel cathode and two different Raney-nickel-coated cathodes posessing comparable loading and effective surface (a) smooth nickel. Raney nickel prepared from two different precursors (b) plasma-sprayed NiAh, (c) NiAU cold rolled together with Mond nickel. Fig. 14. Comparison of the current-voltage curves of a smooth nickel cathode and two different Raney-nickel-coated cathodes posessing comparable loading and effective surface (a) smooth nickel. Raney nickel prepared from two different precursors (b) plasma-sprayed NiAh, (c) NiAU cold rolled together with Mond nickel.
Fig. 8.26 Comparison of Ti02 (A) (untreated) with Ti02 (B) (plasma treated) for NO removal. Fig. 8.26 Comparison of Ti02 (A) (untreated) with Ti02 (B) (plasma treated) for NO removal.
Turban, G. Catherine, Y. Grolleau, B. Plasma Chem. Plasma Proc. 1982, 2, 61. [Pg.442]

Figure 12.4 Systematic methods development samples, (a) Heat plasma blank (b) plasma blank spiked with standards (c) 80% SFE window (d) heated plasma/standards (e) SFE win-dowed/plasma standards (f) SFE windowed patient sample. Figure 12.4 Systematic methods development samples, (a) Heat plasma blank (b) plasma blank spiked with standards (c) 80% SFE window (d) heated plasma/standards (e) SFE win-dowed/plasma standards (f) SFE windowed patient sample.
Fig. 5.34. (a) High-speed photograph (source Fraunhofer FEP, Dresden) and (b) plasma simulation of an MF magnetron in-line sputter process (source Fraunhofer 1ST, Braunschweig)... [Pg.229]


See other pages where B Plasma is mentioned: [Pg.2802]    [Pg.110]    [Pg.167]    [Pg.967]    [Pg.244]    [Pg.127]    [Pg.35]    [Pg.471]    [Pg.472]    [Pg.114]    [Pg.574]    [Pg.177]    [Pg.373]    [Pg.140]    [Pg.351]    [Pg.354]    [Pg.174]    [Pg.65]    [Pg.110]    [Pg.409]    [Pg.617]    [Pg.7]    [Pg.97]    [Pg.98]    [Pg.218]    [Pg.427]    [Pg.475]   


SEARCH



Time Course of Drug Plasma Levels during Irregular Intake (B)

Use of Radio-Frequency Plasma S. M. L. Hamblyn and B. G. Reuben

© 2024 chempedia.info